Patrick Wood
Stock Analyst at UBS
(0.96)
# 3,983
Out of 5,085 analysts
444
Total ratings
52.5%
Success rate
-1.4%
Average return
Main Sectors:
Stocks Rated by Patrick Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IART Integra LifeSciences Holdings | Rated: Hold | $19 → $14 | $12.24 | +14.38% | 5 | Oct 27, 2026 | |
| SOLV Solventum | Reiterated: Buy | $101 | $81.85 | +23.40% | 15 | Oct 26, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $500 | $444.18 | +12.57% | 14 | Oct 13, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $110 | $91.78 | +19.85% | 18 | Oct 7, 2026 | |
| ENOV Enovis | Reiterated: Buy | $51 → $44 | $21.91 | +100.82% | 2 | Oct 5, 2026 | |
| BBNX Beta Bionics | Reiterated: Buy | $22 → $25 | $17.85 | +40.06% | 2 | Sep 15, 2026 | |
| COO The Cooper Companies | Rated: Hold | $75 → $66 | $59.41 | +11.09% | 16 | Sep 10, 2026 | |
| MDT Medtronic | Rated: Buy | $100 → $110 | $94.78 | +16.06% | 17 | Sep 3, 2026 | |
| MMED MiniMed Group | Reiterated: Buy | $25 → $28 | $19.21 | +45.76% | 2 | Sep 2, 2026 | |
| BDX Becton, Dickinson and Company | Rated: Buy | $190 → $205 | $195.16 | +5.04% | 17 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $150 | $148.93 | +0.72% | 17 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $145 → $158 | $138.98 | +13.69% | 16 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $27 → $28 | $19.48 | +43.74% | 8 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $275 → $270 | $228.78 | +18.02% | 12 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 | $19.68 | -8.54% | 15 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5.5 → $6.3 | $4.90 | +28.57% | 18 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $8 | $9.24 | -13.42% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 → $120 | $96.39 | +24.49% | 11 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $15 → $16 | $11.45 | +39.74% | 7 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $20.20 | -0.99% | 10 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $80 → $77 | $66.90 | +15.10% | 24 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $25 | $21.83 | +14.52% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 → $23 | $20.40 | +12.75% | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $118 → $67 | $42.43 | +57.91% | 21 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $72 → $172 | $181.43 | -5.20% | 10 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $137 → $125 | $102.64 | +21.78% | 13 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $15 → $25 | $25.46 | -1.81% | 15 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $96 | $78.62 | +22.11% | 16 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $100 → $82 | $81.26 | +0.91% | 5 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $39 | $70.97 | -45.05% | 6 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $13 → $20 | $24.61 | -18.73% | 11 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $445 → $400 | $304.00 | +31.58% | 7 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 66.22 | CHF 57.64 | +14.88% | 11 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $32.37 | +48.29% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $35 | $59.10 | -40.78% | 4 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 → $85 | $75.82 | +12.11% | 15 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $195 → $205 | $123.99 | +65.34% | 5 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $185 | $373.98 | -50.53% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $195 → $220 | $424.27 | -48.15% | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $266 | $318.31 | -16.43% | 2 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $560 → $656 | $704.15 | n/a | 2 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 | $76.61 | n/a | 1 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 | $16.69 | n/a | 1 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $220 | $279.04 | n/a | 1 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $0.8247 | n/a | 3 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 | $0.02 | n/a | 2 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $34 | $19.43 | n/a | 1 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $16 | $27.03 | n/a | 2 | Oct 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 1,473p | 1,120p | n/a | 1 | Feb 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €35.31 → €45.00 | €24.24 | n/a | 2 | Jul 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €64.58 → €42.00 | €46.34 | n/a | 2 | Dec 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 267.00 | CHF 629.80 | n/a | 1 | Jan 31, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $22.62 | n/a | 1 | Jul 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $183.93 | n/a | 2 | Dec 11, 2017 |
Integra LifeSciences Holdings
Oct 27, 2026
Rated: Hold
Price Target: $19 → $14
Current: $12.24
Upside: +14.38%
Solventum
Oct 26, 2026
Reiterated: Buy
Price Target: $101
Current: $81.85
Upside: +23.40%
Intuitive Surgical
Oct 13, 2026
Reiterated: Buy
Price Target: $500
Current: $444.18
Upside: +12.57%
Edwards Lifesciences
Oct 7, 2026
Reiterated: Buy
Price Target: $110
Current: $91.78
Upside: +19.85%
Enovis
Oct 5, 2026
Reiterated: Buy
Price Target: $51 → $44
Current: $21.91
Upside: +100.82%
Beta Bionics
Sep 15, 2026
Reiterated: Buy
Price Target: $22 → $25
Current: $17.85
Upside: +40.06%
The Cooper Companies
Sep 10, 2026
Rated: Hold
Price Target: $75 → $66
Current: $59.41
Upside: +11.09%
Medtronic
Sep 3, 2026
Rated: Buy
Price Target: $100 → $110
Current: $94.78
Upside: +16.06%
MiniMed Group
Sep 2, 2026
Reiterated: Buy
Price Target: $25 → $28
Current: $19.21
Upside: +45.76%
Becton, Dickinson and Company
Aug 12, 2026
Rated: Buy
Price Target: $190 → $205
Current: $195.16
Upside: +5.04%
Aug 12, 2026
Rated: Hold
Price Target: $150
Current: $148.93
Upside: +0.72%
Aug 11, 2026
Reiterated: Hold
Price Target: $145 → $158
Current: $138.98
Upside: +13.69%
Aug 10, 2026
Rated: Buy
Price Target: $27 → $28
Current: $19.48
Upside: +43.74%
Aug 7, 2026
Rated: Buy
Price Target: $275 → $270
Current: $228.78
Upside: +18.02%
Aug 7, 2026
Reiterated: Hold
Price Target: $18
Current: $19.68
Upside: -8.54%
Aug 6, 2026
Reiterated: Hold
Price Target: $5.5 → $6.3
Current: $4.90
Upside: +28.57%
Aug 6, 2026
Reiterated: Buy
Price Target: $7 → $8
Current: $9.24
Upside: -13.42%
Aug 6, 2026
Reiterated: Buy
Price Target: $115 → $120
Current: $96.39
Upside: +24.49%
Aug 5, 2026
Rated: Buy
Price Target: $15 → $16
Current: $11.45
Upside: +39.74%
Aug 5, 2026
Reiterated: Hold
Price Target: $20
Current: $20.20
Upside: -0.99%
Aug 5, 2026
Rated: Hold
Price Target: $80 → $77
Current: $66.90
Upside: +15.10%
Aug 4, 2026
Reiterated: Buy
Price Target: $24 → $25
Current: $21.83
Upside: +14.52%
Jul 30, 2026
Initiated Coverage: Buy
Price Target: $21 → $23
Current: $20.40
Upside: +12.75%
Jul 30, 2026
Reiterated: Buy
Price Target: $118 → $67
Current: $42.43
Upside: +57.91%
Jul 30, 2026
Reiterated: Hold
Price Target: $72 → $172
Current: $181.43
Upside: -5.20%
Jul 28, 2026
Rated: Buy
Price Target: $137 → $125
Current: $102.64
Upside: +21.78%
Jul 28, 2026
Rated: Hold
Price Target: $15 → $25
Current: $25.46
Upside: -1.81%
Jul 28, 2026
Reiterated: Buy
Price Target: $75 → $96
Current: $78.62
Upside: +22.11%
Jul 28, 2026
Initiated Coverage: Hold
Price Target: $100 → $82
Current: $81.26
Upside: +0.91%
Jul 28, 2026
Downgraded: Sell
Price Target: $39
Current: $70.97
Upside: -45.05%
Jul 28, 2026
Initiated Coverage: Sell
Price Target: $13 → $20
Current: $24.61
Upside: -18.73%
Jul 28, 2026
Upgraded: Buy
Price Target: $445 → $400
Current: $304.00
Upside: +31.58%
Mar 11, 2026
Reiterated: Hold
Price Target: CHF 66.22
Current: CHF 57.64
Upside: +14.88%
Feb 25, 2026
Reiterated: Buy
Price Target: $48
Current: $32.37
Upside: +48.29%
Feb 17, 2026
Reiterated: Hold
Price Target: $35
Current: $59.10
Upside: -40.78%
Feb 5, 2026
Reiterated: Hold
Price Target: $80 → $85
Current: $75.82
Upside: +12.11%
Dec 2, 2025
Reiterated: Buy
Price Target: $195 → $205
Current: $123.99
Upside: +65.34%
Nov 11, 2025
Reiterated: Hold
Price Target: $185
Current: $373.98
Upside: -50.53%
Nov 11, 2025
Reiterated: Buy
Price Target: $195 → $220
Current: $424.27
Upside: -48.15%
Nov 6, 2025
Reiterated: Hold
Price Target: $266
Current: $318.31
Upside: -16.43%
Oct 28, 2025
Reiterated: Buy
Price Target: $560 → $656
Current: $704.15
Upside: n/a
Aug 12, 2025
Reiterated: Buy
Price Target: $68
Current: $76.61
Upside: n/a
Aug 4, 2025
Reiterated: Hold
Price Target: $12
Current: $16.69
Upside: n/a
Jul 23, 2025
Reiterated: Buy
Price Target: $220
Current: $279.04
Upside: n/a
May 27, 2025
Reiterated: Hold
Price Target: $6
Current: $0.8247
Upside: n/a
Jun 13, 2024
Reiterated: Hold
Price Target: $18
Current: $0.02
Upside: n/a
Aug 24, 2023
Downgraded: Hold
Price Target: $34
Current: $19.43
Upside: n/a
Oct 4, 2022
Reiterated: Hold
Price Target: $30 → $16
Current: $27.03
Upside: n/a
Feb 22, 2022
Reiterated: Buy
Price Target: 1,473p
Current: 1,120p
Upside: n/a
Jul 28, 2021
Downgraded: Hold
Price Target: €35.31 → €45.00
Current: €24.24
Upside: n/a
Dec 3, 2020
Downgraded: Hold
Price Target: €64.58 → €42.00
Current: €46.34
Upside: n/a
Jan 31, 2019
Downgraded: Hold
Price Target: CHF 267.00
Current: CHF 629.80
Upside: n/a
Jul 9, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $22.62
Upside: n/a
Dec 11, 2017
Upgraded: Buy
Price Target: n/a
Current: $183.93
Upside: n/a